Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
N Engl J Med
.
2022 Jul 7;387(1):86-88.
doi: 10.1056/NEJMc2206576.
Epub 2022 Jun 22.
Authors
Nicole P Hachmann
1
,
Jessica Miller
1
,
Ai-Ris Y Collier
1
,
John D Ventura
1
,
Jingyou Yu
1
,
Marjorie Rowe
1
,
Esther A Bondzie
1
,
Olivia Powers
1
,
Nehalee Surve
1
,
Kevin Hall
1
,
Dan H Barouch
1
Affiliation
1
Beth Israel Deaconess Medical Center, Boston, MA
[email protected]
.
PMID:
35731894
PMCID:
PMC9258748
DOI:
10.1056/NEJMc2206576
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Neutralizing* / immunology
COVID-19* / immunology
COVID-19* / virology
Humans
SARS-CoV-2* / immunology
Substances
Antibodies, Neutralizing
Supplementary concepts
SARS-CoV-2 variants
Grants and funding
K12 HD000849/HD/NICHD NIH HHS/United States
CA260476/CA/NCI NIH HHS/United States
U01 CA260476/CA/NCI NIH HHS/United States
R21 AI169309/AI/NIAID NIH HHS/United States